BIOLIFE SOLUTIONS INC·4

Jan 23, 8:05 PM ET

Mathers James 4

4 · BIOLIFE SOLUTIONS INC · Filed Jan 23, 2020

Insider Transaction Report

Form 4
Period: 2020-01-21
Mathers James
Vice President of Sales
Transactions
  • Sale

    Common Stock

    2020-01-22$15.68/sh2,500$39,20017,384 total
  • Sale

    Common Stock

    2020-01-23$15.11/sh2,500$37,77517,384 total
  • Exercise/Conversion

    Employee Stock Option

    2020-01-212,5007,613 total
    Exercise: $1.64From: 2019-03-01Exp: 2021-12-20Common Stock (2,500 underlying)
  • Exercise/Conversion

    Common Stock

    2020-01-21$1.64/sh+2,500$4,10019,884 total
  • Exercise/Conversion

    Common Stock

    2020-01-22$1.64/sh+2,500$4,10019,884 total
  • Exercise/Conversion

    Common Stock

    2020-01-23$1.64/sh+2,500$4,10019,884 total
  • Exercise/Conversion

    Employee Stock Option

    2020-01-222,5005,113 total
    Exercise: $1.64From: 2019-03-01Exp: 2021-12-20Common Stock (2,500 underlying)
  • Exercise/Conversion

    Employee Stock Option

    2020-01-232,5002,613 total
    Exercise: $1.64From: 2019-03-01Exp: 2021-12-20Common Stock (2,500 underlying)
  • Sale

    Common Stock

    2020-01-21$15.69/sh2,500$39,22517,384 total
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.56 to $15.82, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.10 to $15.11, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4